Rejected at 2:18 p.m. Oct, 09, 2023 ] by Cameron
Author: salmanumer
Related Note: 1499356681408 1
Rationale for change

"Maintenance pharmacotherapy: similar to that of open-angle glaucoma (see treatment of open-angle glaucoma for further details)"

both types have same pharmacotherapy
Source: AMBOSS - https://www.amboss.com/us/knowledge/glaucoma/

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#AMBOSS::b3aHS4 #AK_Step1_v12::#B&B::17_Ophthalmology::01_General::04_Glaucoma #AK_Other::AnKing_Image::Mujeeb::Glaucoma_therapy::Open/Closed #AK_Other::AnKing_Image::Mujeeb::Glaucoma_therapy #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step2_v12::#AMBOSS::YL0nwg #PANCE::EENT::Eye #AK_Other::AnKing_Image::!Subjects::Neurology::Glaucoma_therapy #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Other::^EXPN #AK_Step1_v12::#Bootcamp::Musculoskeletal::15_Pharmacology::01_Arachidonic_Acid_Pathways #AK_Step1_v12::#UWorld::Step::11841 #AK_Step1_v12::#Physeo::09_Pharm::14_Neuro::25_Glaucoma_Increase_Outflow_of_Aqueous_Humor #AK_Step1_v12::#NBME::33 #AK_Step1_v12::#OME::04_Organ_Systems::08_Neuroscience::04_Special_Senses::03_The_Eye_Eye_Pathologies #AK_Step2_v12::#AMBOSS::bL0Hwg #AK_Step2_v12::#SketchyIM::12_Ophthalmology::01_Glaucoma::01_Glaucoma #AK_Step1_v12::#UWorld::COMLEX::25727 #AK_Other::Only_Step_1&2_Overlap #AK_Step2_v12::#UWorld::Step::18671 #AK_Step1_v12::#OME::Clinical::04_Organ_Systems::08_Neuroscience::04_Special_Senses::03_The_Eye_Eye_Pathologies #AK_Step2_v12::#UWorld::COMLEX::103994 #PANCE::EOR::Family_med #AK_Step1_v12::#FirstAid::12_Neurology_and_Special_Senses::06_Pharm::18_Glaucoma_therapy::*Glaucoma_drugs::Latanoprost_Bimatoprost #AK_Step1_v12::#FirstAid::05_Pharm::02_Autonomic_Drugs::16_Phosphodiesterase_inhibitors::*PGF2a_Analogs::Latanoprost_Bimatoprost #AK_Step1_v12::#SketchyPharm::04_Smooth_Muscle::01_Vasoactive::03_Prostaglandins,_Prostacyclin,_Bosentan,_PDE5_Inhibitors